|
?:authorAffiliation
|
-
[\'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Virology, Division of Medical Sciences, Harvard University, Boston, MA, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard, Medical School, Boston, MA 02215, USA.\', \'Division of Molecular Medicine, Boston Children\'s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.\', \'Institute of Virology, University Hospital, University of Bonn and German Center for Infection Research (DZIF), Bonn-Cologne, Bonn, Germany.\', \'Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.\', \'Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: rcharles@mgh.harvard.edu.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: lauffen@mit.edu.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. Electronic address: galter@mgh.harvard.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}